Clinical inertia among patients with type 2 diabetes mellitus treated with DPP-4i and/or SGLT-2i
- 1 December 2018
- journal article
- research article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 146, 162-171
Abstract
No abstract availableKeywords
Funding Information
- European Foundation for the Study of Diabetes
- Federal Ministry of Education and Research within the German Competence Network Diabetes Mellitus (01GI1106)
- Innovative Medicines Initiative 2 Joint (115797)
- Union’s Horizon 2020 research and innovation programme
- EFPIA
- JDRF
- The Leona M. and Harry B. Helmsley Charitable Trust
- Diabetes and Research on Patient Stratification initiative
- Novo Nordisk A/S
This publication has 18 references indexed in Scilit:
- Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic reviewDiabetes, Obesity and Metabolism, 2017
- Clinical inertia to insulin initiation and intensification in the UK: A focused literature reviewPrimary Care Diabetes, 2017
- Liraglutide and Cardiovascular Outcomes in Type 2 DiabetesNew England Journal of Medicine, 2016
- Progression to insulin therapy among patients with type 2 diabetes treated with sitagliptin or sulphonylurea plus metformin dual therapyDiabetes, Obesity and Metabolism, 2015
- Clinical inertia in the management of type 2 diabetes mellitus: a focused literature reviewBritish Journal of Diabetes, 2015
- Global Guideline for Type 2 DiabetesDiabetes Research and Clinical Practice, 2014
- Clinical Inertia in People With Type 2 DiabetesDiabetes Care, 2013
- 10-Year Follow-up of Intensive Glucose Control in Type 2 DiabetesNew England Journal of Medicine, 2008
- Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trialsAmerican Heart Journal, 2006
- Clinical InertiaAnnals of Internal Medicine, 2001